Pharmaceutical Compliance with Fair Information Practice Principles
Vol. 1, No. 2: February 2002
SUMMARY
Full Text Version
According to a Pew Internet & American Life Project survey (November, 2000), 89% of health seekers on the Internet are concerned that a health Web site might sell or give away information about what they did online. A 2000 Cyber Dialogue survey commissioned by the Internet Healthcare Coalition and the California Healthcare Foundation, found that only 14% of online health seekers have a “high level of trust” of Pharmaceutical company or product web sites.
Fueled by recent privacy laws, such as the Gramm-Leach-Bliley Act and the Health Insurance Portability and Accountability Act, establishing trust and confidence with stakeholders, from regulators to customers, has become a business imperative for the pharmaceutical industry.
How well do pharmaceutical companies’ privacy policies comply with best practices such as the FTC’s Fair Information Practice principles? To determine this, an analysis was performed on the privacy policies of the 21 top selling prescription products worldwide (data from 2000). The results are presente in this article.
Read the full text of this article (PDF format).
